drugset / Trial / NCT01945034

5% Topical Ibuprofen (IBU) for Ankle Sprain

NCT01945034

Phase 3 Completed 304 enrolled Pfizer
RandomizedParallel-groupTriple-blindTreatment

Summary

This study is being conducted to evaluate the effects of IBU 5% Topical Gel versus topical placebo for the relief of pain associated with a first or second degree ankle sprain. Both twice daily and three times daily regimens will be evaluated.

Timeline

Start
2013-11
Primary completion
2015-02
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Ibuprofen Small molecule 5 % Topical

Indications

No indication recorded.